(Q34597743)

3 August 2017

1 reference

title

Management strategies in alcoholic liver disease (English)

1 reference

3 August 2017

Herbert Tilg

1

1 reference

3 August 2017

Christopher P Day

series ordinal

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

Nature Reviews Gastroenterology & Hepatology

3 August 2017

published in

1 reference

3 August 2017

volume

4

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

24-34

1 reference

https://scigraph.springernature.com/pub.10.1038/ncpgasthep0683

3 August 2017

exact match

0 references

cites work

Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

Assessing priorities for allocation of donor liver grafts: survey of public and clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

Ethanol and Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

Review article: current management of alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

The management of alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

EFFECTS OF PROLONGED ETHANOL INTAKE: PRODUCTION OF FATTY LIVER DESPITE ADEQUATE DIETS.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Current concepts in the pathogenesis of alcoholic liver injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Pharmacological treatment of alcohol dependence: a review of the evidence

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Disulfiram treatment of alcoholism. A Veterans Administration cooperative study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Alcoholic hepatitis: clinicopathologic features and therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

MELD accurately predicts mortality in patients with alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

The role of tumor necrosis factor-alpha in acute endotoxin-induced hepatotoxicity in ethanol-fed rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Antibiotics prevent liver injury in rats following long-term exposure to ethanol

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Recent advances in alcoholic liver disease III. Role of the innate immune response in alcoholic hepatitis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

A randomized trial of prednisolone in patients with severe alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Glucocorticosteroids are not effective in alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Alcohol and oxidative liver injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Hepatic vitamin A depletion in alcoholic liver injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Cytokines in alcoholic and nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Managing severe alcoholic hepatitis complicated by renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Long-term treatment of alcoholic liver disease with propylthiouracil

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Inhibition of Collagen Secretion from Bone and Cultured Fibroblasts by Microtubular Disruptive Drugs

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

II. Veterans Affairs Cooperative Study of Polyenylphosphatidylcholine in Alcoholic Liver Disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Liver transplantation in patients with alcoholic cirrhosis: selection criteria and rates of survival and relapse

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Transplantation for alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Liver transplantation for end-stage alcoholic liver disease: an assessment of outcomes

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case-control study and simulated controls

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Orthotopic liver transplantation for alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Alcohol recidivism impairs long-term patient survival after orthotopic liver transplantation for alcoholic liver disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Alcoholism treatment after liver transplantation: lessons learned from a clinical trial that failed

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Liver transplantation for alcoholic liver disease: evaluation of a selection protocol.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Predictive factors of alcohol relapse after orthotopic liver transplantation for alcoholic liver disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Prediction of abstinence from ethanol in alcoholic recipients following liver transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Is liver transplantation an appropriate treatment for acute alcoholic hepatitis?

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Influence of superimposed alcoholic hepatitis on the outcome of liver transplantation for end-stage alcoholic liver disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0683

7 January 2021

Identifiers

DOI

10.1038/NCPGASTHEP0683

1 reference

Dimensions Publication ID

3 August 2017

1051623500

0 references

1 reference